NEUP
Neuphoria Therapeutics Inc.
$4.37
-2.67%
$23.6M
No data for this timeframe.
Vol
Market Cap$23.6M
Cap SizeNano Cap
Analyst ConsensusStrong Buy (88%)
Inst. Holders7 funds
Inst. Value$1.2M
Inst. Activity2 buys / 0 sells
Recent Activity
Inst.
RHUMBLINE ADVISERS — DOUBLED
202 shares ($783.00)
Inst.
MORGAN STANLEY — DOUBLED
58 shares ($225.00)
May 18, 2026
earnings_calendar
NEUP Q3 2026 Earnings Scheduled — 2026-05-18
Price Targets
$7.00
+40.6% upside
Strong Buy
Current $4.98
Low $7.00
Median $7.00
High $7.00
1 analysts
$7.00
$7.00
Analyst Ratings
2Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 15, 2026 | HC Wainwright & Co. | DOWNGRADE | Buy → Neutral |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.56 | $-0.56 — $-0.56 | 90% YoY | 1 |
| Current FY | $-4.07 | $-4.07 — $-4.07 | -1670% YoY | 1 |
| Next FY | $-2.43 ▲ +36.8% | $-2.43 — $-2.43 | 40% YoY | 1 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | $578.7K | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $401.0K | — |
| VANGUARD FIDUCIARY TRUST CO | $136.7K | — |
| CITADEL ADVISORS LLC | $78.7K | — |
| COMMONWEALTH EQUITY SERVICES, LLC | $45.7K | — |
7 institutional holders with $1.2M total value (305,101 shares) as of 2026-Q1. Top holders: BALYASNY, VANGUARD, VANGUARD.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BALYASNY ASSET MANAGEMENT L.P. | 142,183 | $578.7K | 46.6% | — |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 98,516 | $401.0K | 32.3% | — |
| 3 | VANGUARD FIDUCIARY TRUST CO | 33,589 | $136.7K | 11.0% | — |
| 4 | CITADEL ADVISORS LLC | 19,331 | $78.7K | 6.3% | — |
| 5 | COMMONWEALTH EQUITY SERVICES, LLC | 11,222 | $45.7K | 3.7% | — |
| 6 | RHUMBLINE ADVISERS | 202 | $822.00 | 0.1% | DOUBLED +512.1% |
| 7 | MORGAN STANLEY | 58 | $236.00 | 0.0% | DOUBLED +728.6% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | DOUBLED | 33 | 202 | +512.1% | $783.00 | 2025-Q4 |
| MORGAN STANLEY | DOUBLED | 7 | 58 | +728.6% | $225.00 | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 1 | 17 | +1600.0% | $201.00 | 2025-Q3 |
| RHUMBLINE ADVISERS | NEAR_EXIT | 415 | 33 | -92.0% | $234.00 | 2025-Q2 |
| RHUMBLINE ADVISERS | TRIM | 1,106 | 415 | -62.5% | $2.4K | 2025-Q1 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (88% buy). Based on 8 analysts: 2 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$7.00 mean target
+40.6% upside
Strong Buy (1.00)
$7.00 Low
$7.00 High
| Metric | Value |
|---|---|
| Current Price | $4.98 |
| Target Low | $7.00 |
| Target Mean | $7.00 |
| Target Median | $7.00 |
| Target High | $7.00 |
| # Analysts | 1 |
| Recommendation | Strong Buy (1.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.56 | $-0.56 | $-0.56 | 89.9% | +0.0% | 0↑ 1↓ | $0.0B | 100.0% | 1 |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 0.0% | — |
| Current FY 2026-06-30 |
$-4.07 | $-4.07 | $-4.07 | -1669.6% | +0.0% | 0↑ 1↓ | $0.0B | -100.0% | 1 |
| Next FY 2027-06-30 |
$-2.43 | $-2.43 | $-2.43 | 40.3% | +36.8% | 0↑ 1↓ | $0.0B | 0.0% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.560 | |
| 7d ago | $-0.560 | |
| 30d ago | $-0.560 | |
| 60d ago | $-0.560 | |
| 90d ago | $-0.560 |
1 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 15, 2026 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| May 1, 2026 | 2 | 5 | 2 | 0 | 0 | 78% | |
| Apr 1, 2026 | 2 | 5 | 2 | 0 | 0 | 78% | |
| Mar 1, 2026 | 2 | 5 | 2 | 0 | 0 | 78% | |
| Feb 1, 2026 | 2 | 5 | 2 | 0 | 0 | 78% | |
| Jan 1, 2026 | 2 | 5 | 2 | 0 | 0 | 78% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 18, 2026
earnings_calendar
NEUP Q3 2026 Earnings Scheduled — 2026-05-18